Evidence map›Paper›PMID 34054303›Full record

ArticleJournal of inflammation research2021

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies.

Martin Kulke, Felix Nagel, Lukas Schulig, Norman Geist, Marcel Gabor, Julia Mayerle, Markus M Lerch, Andreas Link, Mihaela Delcea

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Martin KulkeInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.ORCID 0000-0002-2689-2428
Felix NagelInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.ORCID 0000-0003-3456-7075
Lukas SchuligInstitute of Pharmacy, University of Greifswald, Greifswald, Germany.ORCID 0000-0002-4614-3395
Norman GeistInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.ORCID 0000-0001-9671-8882
Marcel GaborInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.
Julia MayerleDepartment of Medicine II, Ludwig-Maximilian University of Munich, Munich, Germany.
Markus M LerchDepartment of Medicine a, University Medicine Greifswald, Greifswald, Germany.
Andreas LinkInstitute of Pharmacy, University of Greifswald, Greifswald, Germany.ORCID 0000-0003-1262-6636
Mihaela DelceaInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.ORCID 0000-0002-0851-9072
Universität Greifswald · DELudwig-Maximilians-Universität München · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough strongly related, the pathophysiological effect of the N34S mutation in the serine protease inhibitor Kazal type 1 (SPINK1) in chronic pancreatitis is still unknown. In this study, we investigate the conformational space of the human cationic trypsin-serine protease inhibitor complex.

methodsSimulations with molecular dynamics, replica exchange, and transition pathway methods are used.

resultsTwo main binding states of the inhibitor to the complex were found, which explicitly relate the influence of the mutation site to conformational changes in the active site of trypsin.

conclusionBased on our result, a hypothesis is formulated that explains the development of chronic pancreatitis through accelerated digestion of the mutant by trypsin.

Indexed as

molecular dynamics simulationsreplica exchangetransition path samplingtrypsinumbrella sampling

Identifiers

PMID34054303
PMCPMC8157096
OpenAlexW3162941653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.